Evidence map›Paper›PMID 40493678›Full record

ArticlePloS one2025

Explainable one-class feature extraction by adaptive resonance for anomaly detection in quality assurance.

Hootan Kamran, Dionne Aleman, Chris McIntosh, Tom Purdie

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hootan KamranDepartment of Mechanical and Industrial Engineering, University of Toronto, Toronto, ONT, Canada.ORCID 0000-0002-7272-3633
Dionne AlemanDepartment of Mechanical and Industrial Engineering, University of Toronto, Toronto, ONT, Canada.
Chris McIntoshDepartment of Medical Biophysics, University of Toronto, Toronto, ONT, Canada.
Tom PurdieDepartment of Medical Biophysics, University of Toronto, Toronto, ONT, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we address the inherent challenges in radiotherapy (RT) plan quality assessment (QA). RT, a prevalent cancer treatment, utilizes high-energy beams to target tumors while sparing adjacent healthy tissues. Typically, an RT plan is refined through several QA cycles by experts to ensure it meets clinical and operational objectives before being considered safe for patient treatment. This iterative process tends to eliminate unacceptable plans, creating a significant class imbalance problem for machine learning efforts aimed at automating the classification of RT plans as either acceptable or not. The complexity of RT treatment plans, coupled with the aforementioned class imbalance issue, introduces a generalization problem that significantly hinders the efficacy of traditional binary classification approaches. We introduce a novel one-class classification framework, using an adaptive neural network architecture, that outperforms both traditional binary and standard one-class classification methods in this imbalanced and complex context, despite the inherent disadvantage of not learning from unacceptable plans. Unlike its predecessors, our method enhances anomaly detection for RT plan QA without compromising on interpretability-a critical feature in healthcare applications, where understanding and trust in automated decisions are paramount. By offering clear insights into decision-making processes, our method allows healthcare professionals to quickly identify and address specific deficiencies in RT plans deemed unacceptable, thereby streamlining the QA process and enhancing patient care efficiency and safety.

Indexed as

NeoplasmsQuality Assurance, Health CareRadiotherapy Planning, Computer-AssistedAlgorithmsHumansMachine LearningNeural Networks, Computer

Identifiers

PMID40493678
PMCPMC12151409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.